Determination of Effective Half-Life (Teff) of Radioactive 131I in Thyroid Cancer Patients

被引:0
|
作者
Vu, H. T. [1 ]
Hrejsa, A. [2 ]
Markovic, A. [2 ]
机构
[1] Rosalind Franklin Univ Med & Sci, N Chicago, IL USA
[2] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] 131I effective half-life (Teff) for patients with thyroid cancer
    Willegaignon, J.
    Malvestiti, Luiz F.
    Guimaraes, Maria I. C.
    Sapienza, Marcelo T.
    Endo, Irene S.
    Neto, Guilherme C.
    Marone, Marilia
    Sordi, Gian-Maria A. A.
    HEALTH PHYSICS, 2006, 91 (02): : 119 - 122
  • [2] Effective half-life of 131I in thyroid cancer patients
    North, DL
    Shearer, DR
    Hennessey, JV
    Donovan, GL
    HEALTH PHYSICS, 2001, 81 (03): : 325 - 329
  • [3] 131I effective half-life and dosimetry in thyroid cancer patients
    Remy, Herve
    Borget, Isabelle
    Lebulieux, Sophie
    Guilabert, Nadine
    Lavielle, Frederic
    Garsi, Jerome
    Bournaud, Claire
    Gupta, Severine
    Schlumberger, Martin
    Ricard, Marcel
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (09) : 1445 - 1450
  • [4] 131I effective half-life in children and adolescents with thyroid cancer patients
    Zhang, Xinyue
    Liu, Bin
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [5] 131I Effective Half-life in Children and Adolescents with Thyroid Cancer Patients
    Zhang, X.
    Liu, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S703 - S704
  • [6] Determination of effective half-life of 131I in thyroid cancer patients using remote dose-rate meter
    Kaaria, Laura
    Lapela, Maria
    Seppanen, Marko
    Hogerman, Mikael
    Ruohola, Johanna
    Algars, Annika
    Noponen, Tommi
    EJNMMI PHYSICS, 2024, 11 (01):
  • [7] I131 Effective Half-Life in Well Differentiated Thyroid Cancer Patients
    Saengsuda, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S824 - S824
  • [8] RhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of 131I
    Menzel, C
    Kranert, WT
    Döbert, N
    Diehl, M
    Fietz, T
    Hamscho, N
    Berner, U
    Grünwald, F
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (07) : 1065 - 1068
  • [9] Determining thyroid 131I effective half-life for the treatment planning of Graves' disease
    Willegaignon, Jose
    Sapienza, Marcelo T.
    Coura Filho, George Barberio
    Traino, Antonio C.
    Buchpiguel, Carlos A.
    MEDICAL PHYSICS, 2013, 40 (02)
  • [10] Increased BMI, diabetes, and decreased GFR are associated with prolonged effective half-life of 131I in thyroid cancer patients
    Kaaria, L.
    Lapela, M.
    Seppanen, M.
    Hogerman, M.
    Ruohola, J.
    Algars, A.
    Noponen, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S368 - S369